The U.S. HHS CMS spent 2018 supporting the transition from fee-based models to value-based payment models. There is evidence that value-based care interest supersedes patient-safety issues.
As reported by Maria Castellucci in Modern Healthcare, the CMS announced that it would force Medicare accountable care organizations to assume downside risk sooner and that it would unveil a mandatory oncology payment model.
Ms. Castellucci reports that the risk-based agenda is in stark contrast to 2017 when HHS was headed by Dr. Tom Price. During his short tenure, mandatory bundled-payment models were rolled back and the industry was uncertain about where the shift to value was headed. The confirmation of Alex Azar as HHS secretary at the start of 2018 signaled a shift.Source: Modern Healthcare